Edition:
United States

BioLine RX Ltd (BLRX.OQ)

BLRX.OQ on NASDAQ Stock Exchange Capital Market

1.01USD
16 Feb 2018
Change (% chg)

-- (--)
Prev Close
$1.01
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
71,750
52-wk High
$1.38
52-wk Low
$0.80

Get access to over 18 million research reports from over 1,700 sources.

For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.

Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.

Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:

  • ownership
  • filings
  • deals
  • private equity
  • third-party document and information retrieval
  • estimates
  • fundamentals
  • economics
  • events
  • news
  • and much, much more…

Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.

Name Age Since Current Position

Aharon Schwartz

75 2003 Chairman of the Board

Philip Serlin

57 2016 Chief Executive Officer

Mali Zeevi

2016 Chief Financial Officer

Merril Gersten

2016 Chief Scientific Officer

Moshe Phillip

59 2004 Vice President of Medical Affairs and Senior Clinical Advisor